Sign In

Also in this Section

The mission of the Portal Hypertension SIG is to promote collaboration and networking among investigators focused on understanding the pathophysiology, diagnosis, prevention and treatment of portal hypertension and its complications.

SIG Leadership

  • Juan G. Abraldes, MD
  • Theo Heller, MD, FAASLD
  • Cristina Ripoll, MD
  • Jonathan Andrew Fallowfield, BSC, BM, PhD
    Steering Committee
  • Brett E. Fortune, MD, MSc
    Steering Committee
  • Jordi Gracia-Sancho, PhD
    Steering Committee
  • Jonel Trebicka, MD, PhD
    Steering Committee
  • Elizabeth C. Verna, MD, MS
    Steering Committee
  • Bette Anne Preston
    Staff Liaison